Administration & Analytics - FluxAI Healthcare Demo

Administration & Analytics

AI System Insights

Based on your system usage patterns, our AI has identified several optimization opportunities:

  • Oncology research queries have increased 43% - consider expanding the knowledge base in this domain
  • Model accuracy has improved 12% after last week's training on clinical trial documents
  • 3 new taxonomy terms detected in recent publications - review suggested additions

System Performance

97.3% 2.1%

User Activity

328 4.3%

AI Model Accuracy

92.8% 3.7%

System Users

User Role Department Last Activity AI Usage Actions
Dr. Jennifer Miller
Admin Oncology Research 10 minutes ago
85%
Dr. Robert Kim
Researcher Neurology Research 2 hours ago
62%
Dr. Sarah Johnson
Data Scientist Genomics Data 1 day ago
93%
Showing 3 of 27 users

AI-Recommended Actions

  • Optimize NLP Model for Medical Terminology

    Model accuracy for specialty fields shows 17% lower performance. AI recommends training on specialty-specific corpus.

  • Update Research Database Connections

    3 new research database APIs are available. Adding these would increase knowledge base coverage by an estimated 12%.

  • Add New Oncology Research Team

    Usage patterns suggest adding dedicated resources for the oncology department would optimize workflow.

AI Model Performance

Entity Recognition
94.7%
2.3% improvement
Relationship Mapping
89.2%
1.8% improvement
Query Understanding
91.3%
0.7% decrease
Hypothesis Generation
86.5%
4.2% improvement

Training Opportunities

Schedule Automated Model Retraining

AI suggests retraining query understanding model with new medical terminology

Research Domain Configuration

Configure specialized research domains and taxonomies

Active Domains

  • Oncology Active
  • Neurology Active
  • Cardiology Active
  • Genomics Active
  • Immunology Active
  • Infectious Disease Updating

Domain Settings: Oncology

AI-Suggested Taxonomy Additions
3 new
  • "CAR-T cell therapy resistance mechanisms"
  • "Tumor microenvironment immunosuppression"
  • "Liquid biopsy circulating tumor DNA markers"